© ifpma 2009ecosoc r&d and access 08 july 2009 access, capacity building and r&d: ifpma...

© IFPMA 2009ECOSOC R&D and Access 08 July 2009

Access, Capacity Building and R&D:Access, Capacity Building and R&D:IFPMA Member Company ProgramsIFPMA Member Company Programs

to help improve Health in Developing Countries to help improve Health in Developing Countries

ECOSOC, Geneva, 8 July 2009ECOSOC, Geneva, 8 July 2009

2 © IFPMA 2009ECOSOC R&D and Access 08 July 2009

Growing Industry Effort to help achieve MDGsGrowing Industry Effort to help achieve MDGs

Additional InitiativesAdditional InitiativesAdditional InitiativesAdditional Initiatives

Chronic DiseasesChronic DiseasesChronic DiseasesChronic Diseases

Child & MaternalChild & MaternalChild & MaternalChild & Maternal

Preventable DiseasesPreventable DiseasesPreventable DiseasesPreventable Diseases

Tropical DiseasesTropical DiseasesTropical DiseasesTropical Diseases

MalariaMalariaMalariaMalaria

TuberculosisTuberculosisTuberculosisTuberculosis

HIV/AIDSHIV/AIDSHIV/AIDSHIV/AIDS

SectionSection

99 99

88 88

11111111

12121212

24242424

20062006

6464

11111111

17171717

10101010

19191919

13131313

13131313

52525252

20072007

135135TOTALSTOTALS

20202020

23232323

12121212

18181818

14141414

14141414

54545454

20082008

155155+ 21+ 21

(26)(26)(26)(26)

24242424

29292929

15151515

21212121

17171717

16161616

54545454

20092009

176 (202)176 (202)


Industry Programs for Access… and moreIndustry Programs for Access… and more

Industry Partnerships to Improve Health in Developing WorldIndustry Partnerships to Improve Health in Developing World

What the programs are doing:What the programs are doing:

• Access (36 % of all programs)Access (36 % of all programs)

• Capacity-Building (55 % of all programs)Capacity-Building (55 % of all programs)

• Education (32 % of all programs)Education (32 % of all programs)

• R&D for DDW* (23 % of all programs)R&D for DDW* (23 % of all programs)

(* DDW = Diseases of the Developing World)(* DDW = Diseases of the Developing World)

(NOTE: Many programs have more than 1 area of activity)(NOTE: Many programs have more than 1 area of activity)


Example: HIV / AIDSExample: HIV / AIDS

Abbott, Boehringer-Ingelheim, Johnson & JohnsonAbbott, Boehringer-Ingelheim, Johnson & Johnson Partners: Elizabeth Glaser Pediatric AIDS FoundationPartners: Elizabeth Glaser Pediatric AIDS Foundation Access – DonationAccess – Donation Capacity Building – TrainingCapacity Building – Training EducationEducation In 17 Developing CountriesIn 17 Developing Countries

Elizabeth Glaser Pediatric AIDS FoundationElizabeth Glaser Pediatric AIDS Foundation

• Trains Health WorkersTrains Health Workers• HIV counselingHIV counseling• Prevention educationPrevention education• Infant feeding educationInfant feeding education• Donation of ARVs for PMTCTDonation of ARVs for PMTCT• Donation of rapid test kitsDonation of rapid test kits


Example: TuberculosisExample: Tuberculosis

Eli Lilly and CompanyEli Lilly and Company Partners: WHO & OthersPartners: WHO & Others Access – Pricing & LicensingAccess – Pricing & Licensing Capacity Building – Support & TrainingCapacity Building – Support & Training EducationEducation In 60 developing countriesIn 60 developing countries

Lilly MDR-TB PartnershipLilly MDR-TB Partnership

• Access to medicinesAccess to medicines• Production Technology TransferProduction Technology Transfer• Training Health WorkersTraining Health Workers• Disease SurveillanceDisease Surveillance• Educating People at RiskEducating People at Risk• Community SupportCommunity Support


Example: MalariaExample: Malaria

PfizerPfizer Partner: London School of Hygiene & Tropical Medicine, KEMRI-Partner: London School of Hygiene & Tropical Medicine, KEMRI-

Wellcome Trust, Health Partners Ghana & othersWellcome Trust, Health Partners Ghana & others Capacity Building – Support & TrainingCapacity Building – Support & Training In Ghana, Kenya, SenegalIn Ghana, Kenya, Senegal

Mobilize Against MalariaMobilize Against Malaria

• Training Health WorkersTraining Health Workers• Technical AssistanceTechnical Assistance• Material supportMaterial support• Sharing Best PracticesSharing Best Practices


Example: Tropical DiseasesExample: Tropical Diseases

Merck KGaAMerck KGaA Partner: Partner: Programme for Research & Training in Tropical Diseases Programme for Research & Training in Tropical Diseases

(TDR), sponsored by UNICEF, UNDP, World Bank & WHO(TDR), sponsored by UNICEF, UNDP, World Bank & WHO Research & DevelopmentResearch & Development

Merck Serono Collaboration with TDRMerck Serono Collaboration with TDR

• Training ResearchersTraining Researchers• Malaria & Sleeping SicknessMalaria & Sleeping Sickness• Screening Compound LibraryScreening Compound Library• Identify new Lead MoleculesIdentify new Lead Molecules


Example: Preventable DiseasesExample: Preventable Diseases

Crucell, GlaxoSmithKline, Merck & Co, sanofi-aventis, WyethCrucell, GlaxoSmithKline, Merck & Co, sanofi-aventis, Wyeth Partners: Partners: GAVI Alliance, WHO & other partners GAVI Alliance, WHO & other partners Access – Donation & PricingAccess – Donation & Pricing Capacity Building – Support & TrainingCapacity Building – Support & Training In many low-income countriesIn many low-income countries

GAVI AllianceGAVI Alliance

• Existing / new vaccines to LDCsExisting / new vaccines to LDCs• Preferential pricing of vaccinesPreferential pricing of vaccines• Donation of vaccinesDonation of vaccines• Technical & Training Support Technical & Training Support


Example: Child & Maternal HealthExample: Child & Maternal Health

Schering-PloughSchering-Plough Partners: Partners: WHO Regional Office for Africa, International Federation of WHO Regional Office for Africa, International Federation of

Gynecology & Obstetrics (FIGO) Gynecology & Obstetrics (FIGO) Capacity Building – TrainingCapacity Building – Training 10 countries in Africa & Latin America10 countries in Africa & Latin America

Postpartum Hemorrhage Training MaterialPostpartum Hemorrhage Training MaterialPostpartum Hemorrhage Training MaterialPostpartum Hemorrhage Training Material

• Postpartum management guidePostpartum management guide• For low resource environmentsFor low resource environments• Complementary posters, etc.Complementary posters, etc.• In English, French & Spanish In English, French & Spanish


Example: Chronic DiseasesExample: Chronic Diseases

Novo Nordisk & RocheNovo Nordisk & Roche Partners: Partners: World Diabetes Federation, Ministries of Health & patient organizations World Diabetes Federation, Ministries of Health & patient organizations Access – DonationAccess – Donation Capacity Building – Support & TrainingCapacity Building – Support & Training Cameroon, DR Congo, Guinea, Tanzania, UgandaCameroon, DR Congo, Guinea, Tanzania, Uganda

Changing Diabetes in ChildrenChanging Diabetes in Children

• Develop infrastructureDevelop infrastructure• Train Health WorkersTrain Health Workers• Guidelines & Education MaterialGuidelines & Education Material• Medicines & Medical SuppliesMedicines & Medical Supplies


Example: Additional Health InitiativesExample: Additional Health Initiatives

Japanese Pharmaceutical Manufacturers Association (JPMA)Japanese Pharmaceutical Manufacturers Association (JPMA) Partners: Partners: WHO, Thailand Ministry of Health WHO, Thailand Ministry of Health Capacity Building – Support & TrainingCapacity Building – Support & Training Bhutan, Cambodia, Laos, ThailandBhutan, Cambodia, Laos, Thailand

Strengthening Quality Control in SE AsiaStrengthening Quality Control in SE Asia

• Improve Medicine QualityImprove Medicine Quality• Train Government PersonnelTrain Government Personnel• Provide Analytical InstrumentsProvide Analytical Instruments• Supply Reference Substances Supply Reference Substances


www.ifpma.org/healthpartnershipswww.ifpma.org/healthpartnerships

Search by Search by Developing Country:Developing Country:

KenyaKenya

43 programs found43 programs found


www.globalhealthprogress.orgwww.globalhealthprogress.org

Find Details of Find Details of Partner OrganizationsPartner Organizations

that Industry works withthat Industry works within different areas…in different areas…


32

43

6

50

8

58

9

75

9

0

10

20

30

40

50

60

70

80

2005 2006 2007 2008 2009

32

43

6

50

8

58

9

75

9

0

10

20

30

40

50

60

70

80

2005 2006 2007 2008 2009

Num

ber

of A

ctiv

e R

esea

rch

and

Dev

elop

men

t Pro

ject

s*N

umbe

r of

Act

ive

Res

earc

h an

d D

evel

opm

ent P

roje

cts*

Num

ber

of A

ctiv

e R

esea

rch

and

Dev

elop

men

t Pro

ject

s*N

umbe

r of

Act

ive

Res

earc

h an

d D

evel

opm

ent P

roje

cts*

*1 project = 1 compound in development *1 project = 1 compound in development or 1 screening program for 1 diseaseor 1 screening program for 1 disease

MedicineMedicineR&D projectsR&D projectsMedicineMedicineR&D projectsR&D projects

VaccineVaccineR&D projectsR&D projectsVaccineVaccineR&D projectsR&D projects

Source: IFPMASource: IFPMA

IFPMA Status Report on DDW R&D - 2009IFPMA Status Report on DDW R&D - 2009

R&D for TDR 10 Priority Diseases:R&D for TDR 10 Priority Diseases:

- Chagas- Chagas

- Dengue- Dengue

- Human African Trypanosomiasis- Human African Trypanosomiasis

- Leishmaniasis- Leishmaniasis

- Leprosy- Leprosy

- Lymphatic Filariasis- Lymphatic Filariasis

- Malaria- Malaria

- Onchocerciasis- Onchocerciasis

- Schistosomiasis- Schistosomiasis

- Tuberculosis- Tuberculosis


Overview of R&D Projects by Disease Area – 2009Overview of R&D Projects by Disease Area – 2009Overview of R&D Projects by Disease Area – 2009Overview of R&D Projects by Disease Area – 2009

DiseaseDiseaseOngoingOngoing

MedicinesMedicinesR&D ProjectsR&D Projects

OngoingOngoingVaccinesVaccines

R&D ProjectsR&D Projects

Approvals Since Approvals Since 20052005

R&D Projects R&D Projects Stopped Stopped

Since 2005Since 2005

TuberculosisTuberculosis 2222 33 00 66

MalariaMalaria 3030 44 22 1212

Other Tropical Other Tropical DiseasesDiseases 2323 22 33 22

TotalsTotals 7575 99 55 2020


Developing World Disease R&D Funders 2007Developing World Disease R&D Funders 2007

USUSGovernmentGovernment

48.9 %48.9 %

USUSGovernmentGovernment

48.9 %48.9 %

Bill & Bill & MelindaMelindaGatesGates

FoundationFoundation17.7 %17.7 %

PharmaPharmaIndustryIndustry9.1 %9.1 %

PharmaPharmaIndustryIndustry9.1 %9.1 %

European CommissionEuropean Commission 4.7 %4.7 %

United Kingdom (Govt)United Kingdom (Govt) 3.9 %3.9 %

Wellcome TrustWellcome Trust 2.3 %2.3 %

Netherlands (Govt)Netherlands (Govt) 1.3 %1.3 %

Pasteur InstitutePasteur Institute 1.2%1.2%

Ireland (Govt)Ireland (Govt) 0.9 %0.9 %

Brazil (Govt)Brazil (Govt) 0.9 %0.9 %

Sweden (Govt)Sweden (Govt) 0.8 %0.8 %

Canada (Govt)Canada (Govt) 0.7%0.7%

Australia (Govt)Australia (Govt) 0.7 %0.7 %

Russia (Govt)Russia (Govt) 0.7 %0.7 %

Belgium (Govt)Belgium (Govt) 0.6 %0.6 %

France (Govt)France (Govt) 0.5 %0.5 %

South Africa (Govt)South Africa (Govt) 0.2 %0.2 %

All Other PhilanthropicAll Other Philanthropic 1.0 %1.0 %

All Other GovtsAll Other Govts 4.4 %4.4 %Source: G-FINDER, George Institute, 2009 Source: G-FINDER, George Institute, 2009



www.ifpma.org/clinicaltrialswww.ifpma.org/clinicaltrials

Terms to search for: “Malaria” & “Vaccine”

Trials conducted in: “Kenya”


Thank You!Thank You!

Ch. Louis-Dunant 15Ch. Louis-Dunant 15P.O. Box 195P.O. Box 195112211211 Geneva 20211 Geneva 20SwitzerlandSwitzerland

Tel: Tel: +41-22-338 32 00+41-22-338 32 00Fax:Fax: +41-22-338 32 99+41-22-338 32 99Email: Email: [email protected]@ifpma.orgWeb:Web: www.ifpma.orgwww.ifpma.org

© ifpma 2009ecosoc r&d and access 08 july 2009 access, capacity building and r&d: ifpma...

Documents

partners partners

research training

ecosoc rd

programs capacity

programs rd

health partners ghana

developing countries

company partners